Category: Biotechnology
Africa Biotechnology
-
T-Cell Therapy Market by Type of Therapy (CAR-T, TCR and TIL), Target Indication, Target Antigen (BCMA, CD19, CD20, CD19 and CD22, HLA, MAGE, PRAME, NY-ESO-1 and LAGE, EBV, HBV and Others), Company Size (Small, Mid-sized and Large), Geographical Regions (North America, Europe, Asia Pacific, Latin America, Middle East and North Africa, and Rest of the World), Leading Players and Sales Forecast of Therapies, Industry Trends and Global Forecasts, Till 2035
... 12% during the forecast period, till 2035. The opportunity for the T-cell therapy market has been distributed across the following segments: Type of Therapy CAR-T TCR TIL Target Indication Multiple Myeloma Large B-Cell Lymphoma Acute ... Read More
-
Drug Discovery Enzymes Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... to USD 3.47 billion by 2032, with an anticipated CAGR of 7.60% over the projection period. Drug discovery enzymes are integral to drug development, expediting synthesis, screening, and optimization processes. Derived from microorganisms and plants, ... Read More
-
Analytical Instrumentation Market, By Product Type (Instruments, Services, and Software), By Technology (Polymerase Chain Reaction, Spectroscopy, Microscopy, Chromatography, Flow Cytometry, Sequencing, Microarray, and Others), By Application (Life Sciences Research & Development, Clinical & Diagnostic Analysis, Food & Beverage Analysis, Forensic Analysis, Environmental Testing, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... and ensuring quality control. The growing focus of companies on ensuring product quality, safety, and adherence to various industry regulations has increased the demand for analytical instruments for testing purposes. Furthermore, technological advancements in analytical ... Read More
-
Rnai Technology Market, By Application (Drug Discovery and Development, Therapeutics, Functional Genomics, Others), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, CROs & CMOs, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... (siRNAs) or microRNAs (miRNAs). It has emerged as a powerful tool for selective inhibition of gene expression and functional genomics screens. RNAi holds immense potential for developing novel therapeutics by silencing specific disease-causing genes. The ... Read More
-
3D Bioprinting Market, By Technology (Syringe/extrusion Bioprinting, Inkjet Bioprinting, Magnetic Levitation Bioprinting, Laser-assisted Bioprinting, and Others), By Component (3D Bioprinters, Biomaterials, and Scaffolds), By Application (Drug Testing and Development, Regenerative Medicine, Food Testing, Research, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
... from 2025 to 2032. Report Description: 3D bioprinting is an emerging and innovative technology that utilizes 3D printers to print human tissues, organs, and biochemicals for medical research and clinical applications. It works by layering ... Read More
-
Cardiac Biomarkers Market, By Product Type (Myocardial Muscle Creatine Kinase, Myoglobin, Troponins, Brain Natriuretic Peptide or NT-proBNP, Ischemia-modified Albumin, and Others), By Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, and Others), By Location of Testing (Laboratory Testing and Point of Care Testing), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... over the past few years driven by the rising incidence of cardiovascular diseases and growing elderly population worldwide who are more prone to cardiac issues. Furthermore, ongoing technological advancements are allowing for the development of ... Read More
-
Stem Cell Therapy Market, By Cell Source (Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells, Others), By Application (Musculoskeletal Disorders, Wounds and Injuries, Cancer, Autoimmune Disorders, Others), By End User (Hospitals, Cell Banks , Academic and Research Institutes), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... promising and emerging field in regenerative medicine that involves the use of stem cells and their derivatives to repair or regenerate damaged tissues and cells. Stem cells are found in all human beings from a ... Read More
-
Influenza Vaccines Market, By Vaccine Type (Inactivated, Live Attenuated), By Valency (Quadrivalent, Trivalent), By Route of Administration (Injection, Nasal Spray), By Age Group (Paediatrics, Adults), By Technology (Egg-Based Flu Vaccines, Cell Culture-Based Flu Vaccines, Recombinant Flu Vaccines), By Distribution Channel (Public, Private), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... element of preventive healthcare for decades. The influenza viruses have the ability to mutate and evolve regularly, necessitating the development of updated vaccines each year. The vaccines work to boost the body's immune response to ... Read More
-
Next Generation Sequencing Market, By Product Type (Instruments, Reagents & Consumables), By Sequencing Type (Whole Genome Sequencing, Whole Exome Sequencing, RNA Sequencing, Targeted Re-sequencing, Others), By Application (Drug Discovery, Personalized Medicine, Genetic Screening, Diagnostics, Others), By End User (Hospitals & Clinics, Academic & Research Institutes, Biopharmaceutical Companies, Clinical Laboratories, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... to the high-throughput DNA sequencing technologies that have substantially decreased the cost and increased the speed and throughput of DNA sequencing as compared to the first-generation Sanger sequencing. NGS allows researchers to sequence entire genomes, ... Read More
-
2025 Ghana Cancer Diagnostics Market - 2024 Supplier Shares and Strategies, 2024-2029 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... any other published source , including 2024 supplier strategies and shares, and 2024-2029 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies ... Read More
-
2025 Morocco Cancer Diagnostics Market - 2024 Supplier Shares and Strategies, 2024-2029 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... any other published source , including 2024 supplier strategies and shares, and 2024-2029 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies ... Read More
-
2025 Egypt Cancer Diagnostics Market - 2024 Supplier Shares and Strategies, 2024-2029 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... any other published source , including 2024 supplier strategies and shares, and 2024-2029 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies ... Read More
-
2025 South Africa Cancer Diagnostics Market - 2024 Supplier Shares and Strategies, 2024-2029 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... from any other published source , including 2024 supplier strategies and shares, and 2024-2029 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new ... Read More
-
2025 Kenya Cancer Diagnostics Market - 2024 Supplier Shares and Strategies, 2024-2029 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... any other published source , including 2024 supplier strategies and shares, and 2024-2029 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies ... Read More
-
2025 Nigeria Cancer Diagnostics Market - 2024 Supplier Shares and Strategies, 2024-2029 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... any other published source , including 2024 supplier strategies and shares, and 2024-2029 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies ... Read More
-
2025 Algeria Cancer Diagnostics Market - 2024 Supplier Shares and Strategies, 2024-2029 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... any other published source , including 2024 supplier strategies and shares, and 2024-2029 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies ... Read More
-
2024-2029 Egypt Immunodiagnostic/Immunoassay Analyzers and Reagents - 2024 Supplier Shares and Competitive Analysis, 2024-2029 Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer Diagnostic, Endocrine Function, Immunoproteins, TDMs, and Special Chemistry Centralized and POC Tests - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers, Market Challenges and Risks
... Tests - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers, Market Challenges and Risks This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities ... Read More
-
2024-2029 Algeria Coagulation/Hemostasis Testing Market - Centralized and POC Analyzers and Consumables - 2024 Supplier Shares, 2024-2029 Segment Volume and Sales Forecasts for over 40 Molecular, Chromogenic and Immunodiagnostic Coagulation/Hemostasis Assays - Growth Strategies, Latest Technologies, Instrumentation Pipeline, Opportunities for Suppliers, Market Challenges and Risks
... Technologies, Instrumentation Pipeline, Opportunities for Suppliers, Market Challenges and Risks Summary This comprehensive report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging business opportunities during the next ... Read More
-
Viral Vector Manufacturing, Non-Viral Vector Manufacturing and Gene Therapy Manufacturing Market by Scale of Operation (Preclinical, Clinical and Commercial), Type of Vector (AAV Vectors, Adenoviral Vectors, Lentiviral Vectors, Retroviral Vectors and Other Vectors), Application Area (Gene Therapies, Cell Therapies and Vaccines), Therapeutic Area (Oncological Disorders, Rare Diseases, Neurological Disorders, Sensory Disorders, Metabolic Disorders, Musculoskeletal Disorders, Blood Disorders, Immunological Disorders and Other Disorders), Type of Manufacturer (In-house and Contract Manufacturing Organizations) and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa, Latin America, and Rest of the World): Industry Trends and Global Forecasts, Till 2035
... (Gene Therapies, Cell Therapies and Vaccines), Therapeutic Area (Oncological Disorders, Rare Diseases, Neurological Disorders, Sensory Disorders, Metabolic Disorders, Musculoskeletal Disorders, Blood Disorders, Immunological Disorders and Other Disorders), Type of Manufacturer (In-house and Contract Manufacturing Organizations) ... Read More
-
T-Cell Therapy Market by Type of Therapy (CAR-T, TCR, and TIL), Target Indications (Acute Lymphoblastic Leukemia, Non-Hodgkin’s Lymphoma, Melanoma, Bladder Cancer, Lung Cancer, Head, and Neck Cancer, Multiple Myeloma, Sarcoma, Chronic Lymphocytic Leukemia, Ovarian Cancer, Esophageal Cancer, Colorectal Cancer, Nasopharyngeal Carcinoma, Hepatocellular Carcinoma, Acute Myeloid Leukemia, and Renal Cell Carcinoma), Target Antigens (CD19, BCMA, CD19/22, EGFR, NY-ESO-1, gp100, p53, EBV, MUC1, WT-1, and Others), and Key Geographical Regions (North America, Europe and Asia Pacific, Latin America, Middle East, and North Africa): Industry Trends and Global Forecasts, Till 2035
... Esophageal Cancer, Colorectal Cancer, Nasopharyngeal Carcinoma, Hepatocellular Carcinoma, Acute Myeloid Leukemia, and Renal Cell Carcinoma), Target Antigens (CD19, BCMA, CD19/22, EGFR, NY-ESO-1, gp100, p53, EBV, MUC1, WT-1, and Others), and Key Geographical Regions (North America, ... Read More
-
Global TCR Therapy Market by Target Indication (Nasopharyngeal Carcinoma, Multiple Myeloma, Head and Neck Carcinoma, Sarcoma, Melanoma, Acute Myeloid Leukemia, Lung Cancer, Ovarian Cancer, and Merkel Cell Cancer), Target Antigen (NY-ESO-1, EBV, gp100, and others), Key Players and Key Geographies (North America, Europe, Asia Pacific, Latin America, Middle East and North Africa, and Rest of the World): Industry Trends and Global Forecasts, Till 2035
... Key Players and Key Geographies (North America, Europe, Asia Pacific, Latin America, Middle East and North Africa, and Rest of the World): Industry Trends and Global Forecasts, Till 2035 Global TCR Therapy Market: Overview As ... Read More
-
AI in Drug Discovery Market in Middle East and Africa
... growth patterns, and forecasts spanning the years 2021 to 2029. Gain insights into a comprehensive understanding of the industry landscape. Please note: the online download version of this report is for a global site license. Read More
-
Biohacking Market Size, Share, Trends, Industry Analysis Report: By Product (Smart Drugs, Sensors, Strains, and Others), Application, End Users, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034
... Strains, and Others), Application, End Users, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034” gives a detailed insight intcurrent market dynamics and provides analysis on ... Read More
-
Middle East & Africa Genotyping Market Forecast to 2031 – Regional Analysis – by Product Type (Instruments, Reagents and Kits, Bioinformatics, and Genotyping Services), Technology (Microarray, Capillary Electrophoresis, Sequencing, Polymerase Chain Reaction (PCR), Matrix-Assisted Laser Desorption / MALDI-TOF, and Other Technologies), Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Animal Genetics, Agricultural Biotechnology, and Other Applications), and End user (Pharmaceutical and Biopharmaceutical Companies, Diagnostic and Research Laboratories, Academic Institutes, and Other End Users)
... 2023 to 2031. Increasing Popularity of Personalized Medicine Bolsters Middle East & Africa Genotyping Market According to the National Health Service of England, personalized medicine is the medical treatment tailored to the unique traits of ... Read More
-
Pharmaceutical Glass Packaging Market Research Report Information by Product Type (Vials, Bottles & Jars, Cartridges & Syringes, Ampoules), by Material Type (Type I, Type II, Type III), by Application (Generic Drugs, Branded Drugs, Biological Drugs), and by Region (North America, Europe, Asia-Pacific, Middle East & Africa, and South America) Market Industry Forecast Till 2032
... and by Region (North America, Europe, Asia-Pacific, Middle East & Africa, and South America) Market Industry Forecast Till 2032 In 2023, the pharmaceutical glass packaging market was estimated to be worth USD 21,354.2 million. According ... Read More
Research Assistance
